Russ M - Search Results

1

Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor.

Schwertz H, Carter JM, Abdudureheman M, Russ M, Buerke U, Schlitt A, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M. Schwertz H, et al. Among authors: russ m. Proteomics. 2007 Dec;7(24):4579-88. doi: 10.1002/pmic.200700734. Proteomics. 2007. PMID: 18072194

2

Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury.

Carter J, Buerke U, Rössner E, Russ M, Schubert S, Schmidt H, Ebelt H, Pruefer D, Schlitt A, Werdan K, Buerke M. Carter J, et al. Among authors: russ m. Br J Pharmacol. 2008 Sep;155(1):93-102. doi: 10.1038/bjp.2008.223. Epub 2008 Jun 9. Br J Pharmacol. 2008. PMID: 18536753 Free PMC article.

3

Effects of aprotinin on gene expression and protein synthesis after ischemia and reperfusion in rats.

Buerke M, Pruefer D, Sankat D, Carter JM, Buerke U, Russ M, Schlitt A, Friedrich I, Börgermann J, Vahl CF, Werdan K. Buerke M, et al. Among authors: russ m. Circulation. 2007 Sep 11;116(11 Suppl):I121-6. doi: 10.1161/CIRCULATIONAHA.106.680249. Circulation. 2007. PMID: 17846291

4

Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.

Schwertz H, Carter JM, Russ M, Schubert S, Schlitt A, Buerke U, Schmidt M, Hillen H, Werdan K, Buerke M. Schwertz H, et al. Among authors: russ m. J Cardiovasc Pharmacol. 2008 Aug;52(2):151-60. doi: 10.1097/FJC.0b013e318180188b. J Cardiovasc Pharmacol. 2008. PMID: 18670364

5

Sodium/hydrogen exchange inhibition with cariporide reduces leukocyte adhesion via P-selectin suppression during inflammation.

Buerke U, Pruefer D, Carter JM, Russ M, Schlitt A, Prondzinsky R, Makowski J, Rohrbach S, Niemann B, Schulze C, Dahm M, Vahl CF, Werdan K, Buerke M. Buerke U, et al. Among authors: russ m. Br J Pharmacol. 2008 Apr;153(8):1678-85. doi: 10.1038/sj.bjp.0707647. Epub 2008 Mar 10. Br J Pharmacol. 2008. PMID: 18332863 Free PMC article.

6

Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.

Russ MA, Prondzinsky R, Christoph A, Schlitt A, Buerke U, Söffker G, Lemm H, Swyter M, Wegener N, Winkler M, Carter JM, Reith S, Werdan K, Buerke M. Russ MA, et al. Crit Care Med. 2007 Dec;35(12):2732-9. doi: 10.1097/01.CCM.0000287524.17358.48. Crit Care Med. 2007. PMID: 17893627 Clinical Trial.

7

Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.

Russ MA, Prondzinsky R, Carter JM, Schlitt A, Ebelt H, Schmidt H, Lemm H, Heinroth K, Soeffker G, Winkler M, Werdan K, Buerke M. Russ MA, et al. Crit Care Med. 2009 Dec;37(12):3017-23. doi: 10.1097/CCM.0b013e3181b0314a. Crit Care Med. 2009. PMID: 19661807

8

Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.

Christoph A, Prondzinsky R, Russ M, Janusch M, Schlitt A, Lemm H, Reith S, Werdan K, Buerke M. Christoph A, et al. Among authors: russ m. Acute Card Care. 2008;10(1):49-57. doi: 10.1080/17482940701358564. Acute Card Care. 2008. PMID: 17924229

9

Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy.

Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K, Buerke M. Buerke U, et al. Among authors: russ m. Shock. 2008 Apr;29(4):497-503. doi: 10.1097/shk.0b013e318142c434. Shock. 2008. PMID: 18598004

10

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.

Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M. Prondzinsky R, et al. Among authors: russ m. Crit Care Med. 2010 Jan;38(1):152-60. doi: 10.1097/CCM.0b013e3181b78671. Crit Care Med. 2010. PMID: 19770739 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters